Challenges with (177)Lu-PSMA-617 radiopharmaceutical therapy in clinical practice Editorial


Authors: Jadvar, H.; Iravani, A.; Bodei, L.; Calais, J.
Title: Challenges with (177)Lu-PSMA-617 radiopharmaceutical therapy in clinical practice
Keywords: cancer survival; treatment response; overall survival; positron emission tomography; clinical practice; prostate specific antigen; progression free survival; tumor volume; signal noise ratio; editorial; kidney failure; proteomics; transcriptomics; histology; prostate cancer; isotope labeling; dosimetry; prostatectomy; radiopharmaceutical agent; radiosensitivity; therapy; bone scintiscanning; personalized medicine; randomized controlled trial (topic); phase 2 clinical trial (topic); phase 3 clinical trial (topic); metabolomics; human; article; single photon emission computed tomography-computed tomography; vipivotide tetraxetan lutetium lu 177
Journal Title: Journal of Nuclear Medicine
Volume: 65
Issue: 12
ISSN: 0161-5505
Publisher: Society of Nuclear Medicine  
Date Published: 2024-12-01
Start Page: 1851
End Page: 1854
Language: English
DOI: 10.2967/jnumed.124.268023
PUBMED: 39299786
PROVIDER: scopus
DOI/URL:
Notes: Article -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Lisa   Bodei
    205 Bodei